A Study of Rucaparib in Patients With Metastatic Castration-resistant Prostate Cancer and Homologous Recombination Gene Deficiency
Clinical trial NCT02952534 · COMPLETED
Trial details
- NCT number
- NCT02952534
- Sponsor
- pharmaand GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-15
- Primary completion
- 2021-07-18
- Enrollment
- 277
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.